Enfusion (ENFN) Competitors $9.05 +0.14 (+1.57%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ENFN vs. BOX, PWSC, QLYS, BLKB, NCNO, WK, ZI, CLBT, ALKT, and INTAShould you be buying Enfusion stock or one of its competitors? The main competitors of Enfusion include BOX (BOX), PowerSchool (PWSC), Qualys (QLYS), Blackbaud (BLKB), nCino (NCNO), Workiva (WK), ZoomInfo Technologies (ZI), Cellebrite DI (CLBT), Alkami Technology (ALKT), and Intapp (INTA). These companies are all part of the "prepackaged software" industry. Enfusion vs. BOX PowerSchool Qualys Blackbaud nCino Workiva ZoomInfo Technologies Cellebrite DI Alkami Technology Intapp Enfusion (NYSE:ENFN) and BOX (NYSE:BOX) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership, media sentiment, community ranking and earnings. Which has more volatility and risk, ENFN or BOX? Enfusion has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, BOX has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Does the media favor ENFN or BOX? In the previous week, Enfusion had 2 more articles in the media than BOX. MarketBeat recorded 5 mentions for Enfusion and 3 mentions for BOX. BOX's average media sentiment score of 1.42 beat Enfusion's score of 0.78 indicating that BOX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enfusion 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BOX 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ENFN or BOX? Enfusion currently has a consensus target price of $9.33, indicating a potential upside of 3.13%. BOX has a consensus target price of $31.22, indicating a potential downside of 2.19%. Given Enfusion's higher probable upside, equities analysts clearly believe Enfusion is more favorable than BOX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enfusion 3 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67BOX 1 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has stronger earnings and valuation, ENFN or BOX? BOX has higher revenue and earnings than Enfusion. BOX is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnfusion$174.54M6.66$6.03M$0.04226.31BOX$1.04B4.41$129.03M$0.7940.41 Does the MarketBeat Community prefer ENFN or BOX? BOX received 791 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 71.62% of users gave BOX an outperform vote while only 18.75% of users gave Enfusion an outperform vote. CompanyUnderperformOutperformEnfusionOutperform Votes918.75%Underperform Votes3981.25% BOXOutperform Votes80071.62% Underperform Votes31728.38% Is ENFN or BOX more profitable? BOX has a net margin of 13.94% compared to Enfusion's net margin of 1.98%. Enfusion's return on equity of 6.17% beat BOX's return on equity.Company Net Margins Return on Equity Return on Assets Enfusion1.98% 6.17% 4.51% BOX 13.94%-14.41%5.70% Do institutionals and insiders hold more shares of ENFN or BOX? 81.1% of Enfusion shares are held by institutional investors. Comparatively, 86.7% of BOX shares are held by institutional investors. 36.4% of Enfusion shares are held by company insiders. Comparatively, 4.1% of BOX shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryBOX beats Enfusion on 11 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. Get Enfusion News Delivered to You Automatically Sign up to receive the latest news and ratings for ENFN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENFN vs. The Competition Export to ExcelMetricEnfusionPrepackaged software IndustryComputer SectorNYSE ExchangeMarket Cap$1.16B$23.39B$23.79B$19.25BDividend YieldN/A2.28%2.73%3.53%P/E Ratio226.3162.77263.7643.31Price / Sales6.668.343,710.5214.53Price / Cash62.5183.1532.0120.89Price / Book14.8410.186.985.40Net Income$6.03M$442.81M$669.23M$985.39M7 Day Performance1.00%1.05%-0.32%-0.71%1 Month Performance0.89%0.79%0.65%-0.97%1 Year Performance8.77%21.77%20.22%25.05% Enfusion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENFNEnfusion2.5929 of 5 stars$9.05+1.6%$9.33+3.1%+15.0%$1.16B$174.54M226.311,102Upcoming EarningsShort Interest ↓News CoverageBOXBOX4.0858 of 5 stars$32.27+0.7%$31.22-3.2%+29.7%$4.66B$1.06B40.852,530Positive NewsPWSCPowerSchoolN/A$22.81flat$24.02+5.3%N/A$4.65B$740.86M-95.043,563Upcoming EarningsQLYSQualys2.2185 of 5 stars$122.84+1.4%$144.23+17.4%-20.8%$4.52B$554.46M27.062,188Upcoming EarningsBLKBBlackbaud4.32 of 5 stars$86.58+1.2%$90.67+4.7%+9.6%$4.47B$1.14B109.593,000Analyst DowngradeNews CoverageNCNOnCino2.7568 of 5 stars$38.15+0.8%$38.82+1.8%+34.7%$4.39B$506.13M-141.291,653WKWorkiva3.4987 of 5 stars$78.38-0.5%$95.00+21.2%-7.0%$4.33B$630.04M-47.502,526Upcoming EarningsNews CoverageZIZoomInfo Technologies2.6504 of 5 stars$10.88+3.7%$13.40+23.2%-9.6%$3.97B$1.24B272.073,516CLBTCellebrite DI2.0558 of 5 stars$18.35+0.3%$18.57+1.2%+170.5%$3.78B$325.11M-34.621,008Upcoming EarningsShort Interest ↑News CoverageALKTAlkami Technology3.078 of 5 stars$38.44+0.5%$33.89-11.8%+113.6%$3.75B$297.36M-71.19850Analyst ForecastShort Interest ↓News CoverageINTAIntapp2.2979 of 5 stars$50.35+0.2%$50.00-0.7%+47.4%$3.70B$430.52M-111.891,235Upcoming EarningsNews Coverage Related Companies and Tools Related Companies BOX Alternatives PWSC Alternatives QLYS Alternatives BLKB Alternatives NCNO Alternatives WK Alternatives ZI Alternatives CLBT Alternatives ALKT Alternatives INTA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ENFN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enfusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enfusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.